ArticlePloS one2013

Low dose decitabine treatment induces CD80 expression in cancer cells and stimulates tumor specific cytotoxic T lymphocyte responses.

Li-Xin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.